Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 1/20 | 0.47 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6507174 | 1.00 | DDB1 (0.47) | DDB1CRBNALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL24093870 | 0.86 | DDB1 (0.49) | DDB1CRBNALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL10670488 | 0.86 | DDB1 (0.49) | DDB1CRBNALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL7373854 | 0.85 | DDB1 (0.42) | DDB1CRBNALDH1A1 | |
| SCHEMBL6480024 | 0.85 | DDB1 (0.42) | DDB1CRBNALDH1A1 | |
| SCHEMBL7367294 | 0.85 | DDB1 (0.42) | DDB1CRBN | |
| SCHEMBL7371206 | 0.84 | ALDH1A1 (0.49) | DDB1CRBNALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL3660749 | 0.82 | DDB1 (0.48) | DDB1CRBNALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL8141759 | 0.82 | DDB1 (0.48) | DDB1CRBNALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL11172940 | 0.79 | DDB1 (0.45) | DDB1CRBNALDH1A1MAPK1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1995033731-A1 | HYDROXAMIC ACID DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 1995-12-14 | — | — | WO | disclosed |